IP Library Granted Patent US 9,795,737
Granted Patent B2
US 9,795,737 · App. 13/834,571 · Granted Oct 24, 2017

Method and system for closed-loop control of an artificial pancreas

Inventors: Daniel Finan (Philadelphia, PA); Thomas McCann (Pottstown, PA)
Assignee: ANIMAS CORPORATION
A61M5/1723A61B5/14532A61B5/4839A61M5/14244G06F19/3468A61M2005/14296A61M2205/3553A61M2205/3561A61M2205/3584A61M2205/3592A61M2205/50A61M2205/502A61M2205/52A61M2209/01A61M2230/201G06F19/3437
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,737
App. No.
13/834,571
Granted
Oct 24, 2017
Kind
B2
Abstract

Methods and systems for controlling an insulin pump in response to glucose measurements are responsive to a base insulin delivery profile and a temporary insulin delivery profile. These can be used, e.g., to control blood glucose level of a subject using a continuous glucose monitor and an insulin infusion pump. During a selected time range, an insulin amount for the pump to supply is determined using the temporary insulin delivery profile. Outside that time range, the insulin amount is determined using the base insulin delivery profile. The temporary insulin delivery profile can specify an exact amount to be supplied (a “hard” profile), a nominal amount to be supplied if doing so does not drive glucose out of a desired zone (“soft”), or a soft profile with a minimum amount of insulin to be delivered (“semi-soft”).

Claims (34)

1. Apparatus for the delivery of insulin, the apparatus comprising:

a) a glucose monitor adapted to measure respective glucose levels of a subject at discrete time intervals and provide respective glucose measurement data indicating each measured glucose level;

b) an insulin infusion pump configured to deliver insulin in response to a delivery control signal;

c) a memory configured to store a base insulin delivery profile;

d) an interface adapted to selectively receive a temporary insulin delivery profile extending over a selected time range of the time intervals and to provide a first signal indicating whether the temporary insulin delivery profile was received; and

e) a controller adapted to, for each of a plurality of the discrete time intervals:

i) receive the glucose measurement data for that time interval from the glucose monitor;

ii) determine an insulin delivery amount for that time interval using the received temporary insulin delivery profile when the time interval is in the selected time range and in response to the first signal and, when the time interval is outside the selected time range, using model predictive control based on a selected target glucose concentration range, the received glucose measurement data, and the stored base insulin delivery profile; and

iii) provide to the insulin infusion pump a delivery control signal corresponding to the determined insulin delivery amount, whereby a corresponding amount of insulin is delivered.

2. The apparatus according to claim 1 , wherein the interface is adapted to receive the temporary insulin delivery profile by receiving change information and modifying the stored base insulin delivery profile in the selected time range according to the change information to provide the temporary insulin delivery profile.

3. The apparatus according to claim 1 , wherein the controller is adapted to determine the insulin delivery amount for a selected time interval using:

a) if the temporary insulin delivery profile was not received or the selected time interval is outside the selected time range, the controller is adapted to use the selected target glucose concentration range, the received glucose measurement data, the stored base insulin delivery profile;

b) otherwise, the controller is adapted to use the selected target glucose concentration range, the received glucose measurement data, and the received temporary insulin delivery profile.

4. The apparatus according to claim 1 , wherein the controller is further adapted to, in response to the first signal and if a selected time interval is in the selected time range, constrain the determined insulin delivery amount for the selected time interval to be at least a difference between respective values of the temporary insulin delivery profile and the stored base insulin delivery profile for the selected time interval.

5. The apparatus according to claim 1 , wherein the controller is further adapted to:

a) predict an excursion of a glucose level of the subject from the selected target glucose range using a safety model and at least some of the glucose measurement data for a plurality of the time intervals; and

b) reduce the determined insulin delivery amount according to the predicted excursion.

6. The apparatus according to claim 1 , wherein the temporary insulin delivery profile defines a first subrange and a second subrange of the selected time range and wherein the temporary insulin delivery profile specifies a higher rate of insulin delivery in the first subrange and a lower rate of insulin delivery in the second subrange.

7. The apparatus according to claim 1 , wherein the glucose monitor includes a plurality of glucose sensors.

8. The apparatus according to claim 1 , wherein the interface is further adapted to provide an activation signal and the controller, in response to the activation signal, retrieves the stored base insulin delivery profile and retrieves or determines the insulin delivery amount.

9. Apparatus for the delivery of insulin, the apparatus comprising:

a) a glucose monitor adapted to measure respective glucose levels of a subject at discrete time intervals and provide respective glucose measurement data indicating each measured glucose level;

b) an insulin infusion pump configured to deliver insulin in response to a delivery control signal;

c) a memory configured to store a base insulin delivery profile;

d) an interface adapted to receive a temporary insulin delivery profile extending over a selected time range of the time intervals; and

a controller adapted to, for each of a plurality of the discrete time intervals:

i) receive the glucose measurement data for that time interval from the glucose monitor;

ii) when that time interval is in the selected time range, retrieve a corresponding insulin delivery amount from the temporary insulin delivery profile and when the time interval is outside the selected time range, determine an insulin delivery amount for that time interval using model predictive control based on a selected target glucose concentration range, the received glucose measurement data, and the base insulin delivery profile; and

iii) provide to the insulin infusion pump a delivery control signal corresponding to the insulin delivery amount, whereby a corresponding amount of insulin is delivered.

10. The apparatus according to claim 9 , wherein the controller is further adapted to:

a) predict an excursion of a glucose level of the subject from the selected target glucose range using a safety model and at least some of the glucose measurement data for a plurality of the time intervals; and

b) reduce the determined insulin delivery amount according to the predicted excursion.

11. The apparatus according to claim 9 , wherein the glucose monitor includes a plurality of glucose sensors.

12. The apparatus according to claim 9 , wherein the interface is further adapted to provide an activation signal and the controller, in response to the received activation signal, retrieves the stored base insulin delivery profile and retrieves or determines the insulin delivery amount.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2018
From: ANIMAS LLC
To: JDRF INTERNATIONAL
Reel/Frame 045518/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2013
From: FINAN, DANIEL; MCCANN, THOMAS
To: ANIMAS CORPORATION
Reel/Frame 030013/0105 →
Continuity (1)
Related Publication 20140276554A1 · Sep 18, 2014